华测检测跌2.03%，成交额1.77亿元，主力资金净流出3411.54万元

Core Points - The stock price of Huace Testing fell by 2.03% on October 29, trading at 14.00 CNY per share with a market capitalization of 23.56 billion CNY [1] - The company has seen a year-to-date stock price increase of 14.00%, with a 1.20% decline over the last five trading days [1] - Huace Testing's main business segments include life sciences (43.02%), industrial testing (20.31%), consumer product testing (17.64%), trade assurance (14.39%), and medical services (4.64%) [1] Financial Performance - As of September 30, Huace Testing reported a revenue of 4.702 billion CNY for the first nine months of 2025, representing a year-on-year growth of 6.95% [2] - The net profit attributable to shareholders for the same period was 812 million CNY, reflecting an 8.78% increase year-on-year [2] Shareholder Information - The number of shareholders decreased by 5.62% to 76,600 as of September 30 [2] - The largest shareholder is Hong Kong Central Clearing Limited, holding 289 million shares, an increase of 20.82 million shares from the previous period [3] - The top ten circulating shareholders include various ETFs, with notable changes in holdings among them [3]